The Scientist : Reducing Risks, Maximizing Impact with Cancer Biomarkers [15/3/2004]

by Athos Gianella-Borradori, Bob Jackson and Spiro Rombotis

Reducing Risks, Maximizing Impact with Cancer Biomarkers

The goal is to match novel anticancer agents to the molecular profiles of individual tumors

The Scientist 2004, 18(5):8

15 March 2004

Biomarkers measure drug-induced changes in a patient's blood or tissue. Such changes can confirm drug activity and thereby help select patients more likely to respond to treatment. These biochemicals are revolutionizing cancer drug development.

Password

> Forgot Password?
> FAQ
> Subscribe

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today